INVITATION
Merck KGaA, Darmstadt, Germany – Pfizer Alliance - Optimizing treatment outcomes in advanced urothelial carcinoma and metastatic renal cell carcinoma
INVITATION
Bristol Myers Squibb - Integration of immuno-oncology into the perioperative MIUC treatment landscape